Clinical Trial Update: A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adding Durvalumab after chemotherapy and in combination with surgery for early-stage operable non-small cell lung cancer; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: RECRUITING